--- title: "98 % vs 99 % Peptide Purity: What the Extra Percent Means and When It Matters" description: "What an HPLC purity figure measures, what lives in the missing 1-2 %, which impurities matter for which experiments, and when a 98 % release spec is right." url: https://www.certuspeptides.com/research/peptide-purity-98-vs-99 markdown: https://www.certuspeptides.com/research/peptide-purity-98-vs-99.md site: Certus Peptides --- # 98 % vs 99 % Peptide Purity: What the Extra Percent Means and When It Matters Suppliers compete on purity figures, and 99 % looks obviously better than 98 %. Sometimes it is. But the number is an area percent from a chromatogram, and what it hides matters more than its size: one percent of a harmless truncation is a different situation from one percent of a same-mass diastereomer that is active at the receptor. This guide explains what the figure measures, what the other one or two percent is made of, and when the extra percent is worth paying for. ## What the number is A purity figure on a peptide certificate is almost always reversed-phase HPLC area percent at 214 nm, where the peptide bond absorbs. The sample is separated on a hydrophobic column under a solvent gradient, the detector records every species that absorbs at that wavelength, and purity is the area of the main peak divided by the total area of all peaks. It is a statement about the relative proportions of UV-absorbing species. It says nothing about salt, water or anything that does not absorb, and it says nothing about whether the main peak is the compound named on the label. It is also method-dependent. A shallower gradient resolves more impurities from the main peak and reports a lower purity for the same material. A certificate that reports 99.8 % on a five-minute gradient may be describing a lot that reads 98.9 % on a thirty-minute one. Comparing two suppliers' figures without knowing the methods is comparing two different measurements. ## What lives in the other 1-2 % Deletion sequences, where a coupling step failed and one residue is missing. They are lighter than the target by that residue's mass, from 57 Da for glycine to 186 Da for tryptophan, and they usually elute close to the main peak because they differ by one residue in a long chain. Truncations, where synthesis stopped early and a capped shorter chain was carried through. Incompletely removed side-chain protecting groups: a tert-butyl at +56 Da, a trityl at +242 Da, a Pbf on arginine at +252 Da. Oxidized variants at +16 Da wherever the sequence has a methionine, cysteine or tryptophan. Deamidated variants at +0.98 Da at asparagine or glutamine. Aspartimide rearrangements at the same mass as the target. Diastereomers from epimerization, also at the same mass. Dimers from disulfide formation or aggregation. For cyclic peptides, the linear precursor at +18 Da; for acetylated peptides, the un-acetylated form at -42 Da. Each of these is a distinct peak, or should be. A certificate that shows the chromatogram lets you see how many there are and roughly where they sit. A certificate that shows only the number does not. ## Why the identity of the impurity matters more than its size One percent of a truncated fragment that does not bind the receptor is, for most purposes, a one percent dilution. One percent of a des-acyl semaglutide is a molecule with different receptor kinetics and no albumin binding. One percent of L-epimerized ipamorelin is a diastereomer whose receptor activity is unknown and whose presence is invisible to mass spectrometry. One percent of linear Melanotan II is a molecule that has lost the conformational constraint the whole design depends on. This is why the Certus certificate reports compound-specific lines alongside the purity: linear content for the cyclic melanocortin analogs, diastereomeric purity for ipamorelin, maleimide integrity for CJC-1295 with DAC, copper stoichiometry for GHK-Cu, an aspartimide-resolving gradient for thymosin alpha-1. The purity figure tells you how much is not the main peak. The compound-specific line tells you whether the thing that is not the main peak is the thing that would wreck your experiment. Co-elution is the other reason. If an impurity has nearly the same hydrophobicity as the target it sits under the main peak and inflates the figure. A second gradient on different column chemistry or at a different pH is the standard check, and the orthogonal-gradient linear content assay on the melanocortin analogs exists precisely because cyclic and linear forms can co-elute on a routine method. ## When 98 % is the right specification Certus releases most of the catalog at 99.0 % and a defined set of compounds at 98.0 %: retatrutide, cagrilintide, survodutide, CJC-1295 with DAC, sermorelin, hexarelin and SNAP-8, among others. That is not a lower standard for those products; it is an honest one. Retatrutide is a 39-residue acylated synthesis with several orthogonally protected side chains. CJC-1295 with DAC adds a conjugation step to a 29-mer. Sermorelin has an oxidizable methionine and a rearrangement-prone asparagine and degrades during the analysis itself if it is handled slowly. For these compounds, a supplier quoting 99.5 % on every lot is either running a gradient that cannot see the impurities, or quoting a template. The release specification is a floor; the measured result on the certificate is what you actually received, and Certus lots typically run well above their specification. Read the result, not the specification. For a design that measures a bulk response with a wide dynamic range, 98 % with characterized impurities is adequate and the extra percent buys nothing. For most receptor assays, cell migration work, and anything read out by a large effect, this describes the situation. ## When the extra percent matters It matters when an impurity is active at the same receptor. Near-analog impurities of incretin peptides, deamidated Melanotan II (which is PT-141, a different receptor profile), and epimerized secretagogues all fall here. A one percent impurity with ten times the potency of the target contributes ten percent of the signal. It matters in quantitative binding and kinetics work where the effective concentration of the target must be known precisely. It matters when the material will serve as an in-house reference standard against which other lots are judged, because an impure standard shifts every subsequent measurement. And it matters for the cyclic and stereochemically defined compounds, where the same-mass impurity is the design failure rather than a dilution. In those cases the relevant number is not 98 versus 99 but the compound-specific line: linear content under 0.5 %, diastereomeric purity over 99.0 %, maleimide integrity over 90.0 %. A 99.5 % pure lot with 1 % linear content has failed the assay that matters. ## Purity, content and identity together Purity is one of three numbers. Net peptide content tells you how much of the cake is peptide; identity by LC-MS tells you the main peak is the compound named. A 98 % pure lot at 90 % net content with a confirmed mass contains more of the right molecule per milligram of cake than a 99 % pure lot at 80 % net content with no mass confirmation, and the second certificate has told you less. When you compare suppliers, compare all three, and look for the chromatogram and the deconvoluted spectrum rather than the summary line. The extra percent is real when it is measured on the same method, reported with its impurity profile, and accompanied by the numbers that make it interpretable. ## Questions ### Is 99 % peptide purity better than 98 %? Usually, if both were measured on the same HPLC method. But the identity of the missing percent matters more than its size. One percent of an inactive truncation is a dilution; one percent of a same-mass diastereomer or a des-acyl variant can change receptor behavior. Read the impurity profile and the compound-specific assays, not just the figure. ### What does peptide purity actually measure? Reversed-phase HPLC area percent at 214 nm: the area of the main peak divided by the total area of all UV-absorbing peaks. It measures proportions among peptide species only. It does not see salt or water, does not confirm identity, and depends on the gradient used, so figures from different methods are not directly comparable. ### What are the common impurities in synthetic peptides? Deletion sequences missing one residue, truncated chains, incompletely removed protecting groups such as tert-butyl or Pbf, oxidized methionine or tryptophan at +16 Da, deamidated asparagine or glutamine, aspartimide rearrangements, diastereomers from epimerization, dimers, linear precursors of cyclic peptides, and un-acetylated forms of acetylated peptides. ### Why do some Certus peptides have a 98 % release specification? Because their syntheses are harder. Long acylated incretin peptides, the DAC-conjugated CJC-1295 and unmodified sermorelin have more steps or more degradation pathways than a short, stable sequence. A 98.0 % floor is an honest specification for those compounds; the measured result on each certificate is typically well above it. ## Compounds discussed - https://www.certuspeptides.com/products/retatrutide - https://www.certuspeptides.com/products/ipamorelin - https://www.certuspeptides.com/products/melanotan-ii - https://www.certuspeptides.com/products/cjc-1295-dac ## Keep reading - [How to Read a Peptide Certificate of Analysis](https://www.certuspeptides.com/research/how-to-read-a-certificate-of-analysis) - [HPLC vs Mass Spectrometry: Why Peptide Testing Needs Both](https://www.certuspeptides.com/research/hplc-vs-mass-spec) - [Net Peptide Content Explained: Why 10 mg Is Not Always 10 mg of Peptide](https://www.certuspeptides.com/research/net-peptide-content-explained) - [Melanotan II vs PT-141 (Bremelanotide): Structural Differences and Receptor Selectivity](https://www.certuspeptides.com/research/melanotan-ii-vs-pt-141) Updated 2026-09-26. 8 minute read. Published by Certus Peptides. --- For laboratory and research use only. Not for human or veterinary consumption. Not a drug, food or cosmetic. Sold exclusively to qualified researchers and licensed laboratories. Support: support@certuspeptides.com. Every certificate of analysis: https://www.certuspeptides.com/lab-reports.